Clinical research of method integrated Differential Tongfu and Early Enteral Nutrition of Titration in patients with intra-abdominal hypertension and kidney dysfunction

注册号:

Registration number:

ITMCTR2100004895

最近更新日期:

Date of Last Refreshed on:

2021-05-28

注册时间:

Date of Registration:

2021-05-28

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

辨证通腑法联合早期滴定法肠内营养支持治疗腹腔高压临床研究与机制探讨

Public title:

Clinical research of method integrated Differential Tongfu and Early Enteral Nutrition of Titration in patients with intra-abdominal hypertension and kidney dysfunction

注册题目简写:

English Acronym:

研究课题的正式科学名称:

通腑法联合早期滴定法肠内营养支持对腹腔高压及肾功能等脏器功能影响的临床研究与机制探讨

Scientific title:

Clinical research of method integrated Differential Tongfu and Early Enteral Nutrition of Titration in patients with intra-abdominal hypertension

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100046759 ; ChiMCTR2100004895

申请注册联系人:

朱宏坤

研究负责人:

朱宏坤

Applicant:

Zhu Hongkun

Study leader:

Zhu Hongkun

申请注册联系人电话:

Applicant telephone:

+86 15951977298

研究负责人电话:

Study leader's telephone:

+86 17372215636

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

15951810501@163.com

研究负责人电子邮件:

Study leader's E-mail:

15951810501@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

江苏省汉中路155号江苏省中医院

研究负责人通讯地址:

江苏省汉中路155号

Applicant address:

155 Hanzhong Road, Nanjing, Jiangsu, China

Study leader's address:

155 Hanzhong Road, Nanjing, Jiangsu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

江苏省中医院

Applicant's institution:

Affiliated Hospital of Nanjing University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2015NL-115-02

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

江苏省中医院伦理委员会

Name of the ethic committee:

The Ethic Committee of Jiangsu Provincial Hospital of TCM

伦理委员会批准日期:

Date of approved by ethic committee:

1990/1/1 0:00:00

伦理委员会联系人:

王卯

Contact Name of the ethic committee:

Wang Mao

伦理委员会联系地址:

江苏南京汉中路155号江苏省中医院

Contact Address of the ethic committee:

155 Hanzhong Road, Nanjing, Jiangsu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 25 86617141

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

江苏省中医院

Primary sponsor:

Jiangsu Provincial Hospital of TCM

研究实施负责(组长)单位地址:

江苏省汉中路155号江苏省中医院

Primary sponsor's address:

155 Hanzhong Road, Nanjing, Jiangsu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

南京

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

江苏省中医院

具体地址:

汉中路155号

Institution
hospital:

Jiangsu Provincial Hospital of TCM

Address:

155 Hanzhong Road

经费或物资来源:

江苏省中医药局

Source(s) of funding:

the open topic of jiangsu beau of trational chinese medicine

研究疾病:

腹腔高压,肾功不全

研究疾病代码:

Target disease:

abdominal hypertension Kidney dysfunction

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

研究辨证通腑法联合早期滴定法肠内营养对腹腔高压患者腹腔压力、肾脏等相关器官功能、肠内营养实施安全性、耐受性的影响,并探讨其机制。

Objectives of Study:

To study the effects of syndrome differentiation and tongfu method combined with early titration enteral nutrition on abdominal pressure, kidney and other related organ functions, implementation safety and tolerance of enteral nutrition in patients with abdominal hypertension, and to explore its mechanism.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.入组前均取得患者和家属同意; 2.符合IAH/ACS的诊断标准;符合中医腹胀满的诊断标准; 3.年龄18至70岁之间; 4.均未行开腹手术治疗; 5.从其它地方转诊过来时未接受肠内营养支持; 6.无严重代谢性疾病和消化道其他疾病,如放射性肠炎、短肠综合征等。

Inclusion criteria

1. Consent of patients and their family members was obtained before enrollment; 2. Meet the diagnostic criteria of IAH/ACS; meets the diagnostic criteria of TCM abdominal distension; 3. between the ages of 18 and 70 years; 4. No open surgery was performed; 5. not receiving enteral nutrition support when referred from other places; 6. No serious metabolic diseases and other digestive tract diseases, such as radioactive enteritis, short bowel syndrome, etc.

排除标准:

1.住院时间≥72 h; 2.机械性肠梗阻、消化道大出血; 3.对治疗药物过敏; 4.存在慢性肾功能和/或呼吸功能不全严重基础疾病; 5.频临死亡或复苏失败、无法配合或拒绝完成相关检。

Exclusion criteria:

1. Duration of hospital stay >= 72 h; 2. Mechanical intestinal obstruction and massive gastrointestinal bleeding; 3. Allergic to therapeutic drugs; 4. Severe underlying diseases with chronic renal function and/or respiratory insufficiency; 5. Close to death or failure in resuscitation, inability to cooperate or refusal to complete relevant tests.

研究实施时间:

Study execute time:

From 2016-01-01

To      2021-05-10

征募观察对象时间:

Recruiting time:

From 2016-02-01

To      2021-05-31

干预措施:

Interventions:

组别:

试验组

样本量:

80

Group:

experimental group

Sample size:

干预措施:

中药通腑+基础治疗

干预措施代码:

Intervention:

TCM Tongfu + basic treatment

Intervention code:

组别:

对照组

样本量:

80

Group:

Control group

Sample size:

干预措施:

基础治疗

干预措施代码:

Intervention:

basic treatment

Intervention code:

样本总量 Total sample size : 140

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

江苏

市(区县):

南京

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

江苏省中医院

单位级别:

三甲

Institution/hospital:

Jiangsu Provincial Hospital of TCM

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

机械通气时间

指标类型:

次要指标

Outcome:

Duration of mechanical ventilation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腹腔压力

指标类型:

主要指标

Outcome:

abdominal pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肾功能

指标类型:

主要指标

Outcome:

kidney function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

结束

Completed

年龄范围:

最小 38
Min age years
最大 88
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法或中央计算机法

Randomization Procedure (please state who generates the random number sequence and by what method):

Table of random numbers or The central computer

盲法:

Not stated

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

mail.163.com 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Please contact me if necessary, email will be sent.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above